The Pennsylvania Supreme Court has ruled that physicians may refer injured workers to pharmacies in which they have a financial interest without violating the state’s workers’ compensation anti-self-referral statute, narrowing one of the legal tools used to challenge physician-owned pharmacy arrangements.
The decision stems from the case 700 Pharmacy v. Bureau of Workers’ Compensation Fee Review Hearing Office (State Workers’ Insurance Fund). The court’s majority concluded that the Workers’ Compensation Act’s self-referral prohibition applies only to a specific list of medical services identified in the statute and does not extend to pharmacies or prescription drug services. A dissenting opinion argued that the law should be interpreted more broadly to cover all goods and services, including medications.
The ruling arrives amid longstanding concerns about prescription drug costs in Pennsylvania workers’ compensation claims. Critics of physician-affiliated pharmacies contend that financial relationships between prescribers and pharmacies can lead to significantly higher drug charges than those typically seen at retail pharmacies. Examples cited in the case discussion showed substantial price differences for common medications frequently prescribed in workers’ compensation claims.
For claims professionals, the decision underscores the continuing challenges of controlling pharmacy costs in Pennsylvania, a state already known for higher workers’ compensation drug expenditures. While the ruling limits the use of the workers’ compensation self-referral statute in these disputes, questions remain regarding other potential legal remedies, including challenges under Pennsylvania’s Insurance Fraud Prevention Act and future legislative reforms.
The case is likely to attract attention from insurers, employers, pharmacy benefit managers, and regulators as stakeholders continue to debate the role of physician-owned pharmacies, drug pricing transparency, and cost containment within the workers’ compensation system.
